The global market for Vaccine Administration was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine Administration, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Vaccine Administration by region & country, by Type, and by Application.

The Vaccine Administration market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Administration.

Market Segmentation

Scope of Vaccine Administration - Market Report

Report Metric	Details
Report Name	Vaccine Administration - Market
CAGR	5%
Segment by Type:	Viral Diseases Bacterial Diseases
Segment by Application	Paediatrics Adults
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, AstraZeneca, Sanofi Aventis, Merck, GlaxoSmithKline, Emergent BioSolutions, Johnson & Johnson, CSL Limited, Serum Institute of India, Bharat Biotech, VBI Vaccines, Sinovac Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Vaccine Administration manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Vaccine Administration in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Vaccine Administration in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Vaccine Administration - Market report?

Ans: The main players in the Vaccine Administration - Market are Pfizer, AstraZeneca, Sanofi Aventis, Merck, GlaxoSmithKline, Emergent BioSolutions, Johnson & Johnson, CSL Limited, Serum Institute of India, Bharat Biotech, VBI Vaccines, Sinovac Biotech

What are the Application segmentation covered in the Vaccine Administration - Market report?

Ans: The Applications covered in the Vaccine Administration - Market report are Paediatrics, Adults

What are the Type segmentation covered in the Vaccine Administration - Market report?

Ans: The Types covered in the Vaccine Administration - Market report are Viral Diseases, Bacterial Diseases

1 Market Overview

1.1 Vaccine Administration Product Introduction

1.2 Global Vaccine Administration Market Size Forecast

1.3 Vaccine Administration Market Trends & Drivers

1.3.1 Vaccine Administration Industry Trends

1.3.2 Vaccine Administration Market Drivers & Opportunity

1.3.3 Vaccine Administration Market Challenges

1.3.4 Vaccine Administration Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Vaccine Administration Players Revenue Ranking (2023)

2.2 Global Vaccine Administration Revenue by Company (2019-2024)

2.3 Key Companies Vaccine Administration Manufacturing Base Distribution and Headquarters

2.4 Key Companies Vaccine Administration Product Offered

2.5 Key Companies Time to Begin Mass Production of Vaccine Administration

2.6 Vaccine Administration Market Competitive Analysis

2.6.1 Vaccine Administration Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by Vaccine Administration Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Viral Diseases

3.1.2 Bacterial Diseases

3.2 Global Vaccine Administration Sales Value by Type

3.2.1 Global Vaccine Administration Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Vaccine Administration Sales Value, by Type (2019-2030)

3.2.3 Global Vaccine Administration Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Paediatrics

4.1.2 Adults

4.2 Global Vaccine Administration Sales Value by Application

4.2.1 Global Vaccine Administration Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Vaccine Administration Sales Value, by Application (2019-2030)

4.2.3 Global Vaccine Administration Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global Vaccine Administration Sales Value by Region

5.1.1 Global Vaccine Administration Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Vaccine Administration Sales Value by Region (2019-2024)

5.1.3 Global Vaccine Administration Sales Value by Region (2025-2030)

5.1.4 Global Vaccine Administration Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America Vaccine Administration Sales Value, 2019-2030

5.2.2 North America Vaccine Administration Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe Vaccine Administration Sales Value, 2019-2030

5.3.2 Europe Vaccine Administration Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific Vaccine Administration Sales Value, 2019-2030

5.4.2 Asia Pacific Vaccine Administration Sales Value by Country (%), 2023 VS 2030

5.5 South America

5.5.1 South America Vaccine Administration Sales Value, 2019-2030

5.5.2 South America Vaccine Administration Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa Vaccine Administration Sales Value, 2019-2030

5.6.2 Middle East & Africa Vaccine Administration Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Vaccine Administration Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Vaccine Administration Sales Value

6.3 United States

6.3.1 United States Vaccine Administration Sales Value, 2019-2030

6.3.2 United States Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Vaccine Administration Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Vaccine Administration Sales Value, 2019-2030

6.4.2 Europe Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Vaccine Administration Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Vaccine Administration Sales Value, 2019-2030

6.5.2 China Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.5.3 China Vaccine Administration Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Vaccine Administration Sales Value, 2019-2030

6.6.2 Japan Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Vaccine Administration Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Vaccine Administration Sales Value, 2019-2030

6.7.2 South Korea Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Vaccine Administration Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Vaccine Administration Sales Value, 2019-2030

6.8.2 Southeast Asia Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Vaccine Administration Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Vaccine Administration Sales Value, 2019-2030

6.9.2 India Vaccine Administration Sales Value by Type (%), 2023 VS 2030

6.9.3 India Vaccine Administration Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Pfizer

7.1.1 Pfizer Profile

7.1.2 Pfizer Main Business

7.1.3 Pfizer Vaccine Administration Products, Services and Solutions

7.1.4 Pfizer Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.1.5 Pfizer Recent Developments

7.2 AstraZeneca

7.2.1 AstraZeneca Profile

7.2.2 AstraZeneca Main Business

7.2.3 AstraZeneca Vaccine Administration Products, Services and Solutions

7.2.4 AstraZeneca Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.2.5 AstraZeneca Recent Developments

7.3 Sanofi Aventis

7.3.1 Sanofi Aventis Profile

7.3.2 Sanofi Aventis Main Business

7.3.3 Sanofi Aventis Vaccine Administration Products, Services and Solutions

7.3.4 Sanofi Aventis Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.3.5 Merck Recent Developments

7.4 Merck

7.4.1 Merck Profile

7.4.2 Merck Main Business

7.4.3 Merck Vaccine Administration Products, Services and Solutions

7.4.4 Merck Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.4.5 Merck Recent Developments

7.5 GlaxoSmithKline

7.5.1 GlaxoSmithKline Profile

7.5.2 GlaxoSmithKline Main Business

7.5.3 GlaxoSmithKline Vaccine Administration Products, Services and Solutions

7.5.4 GlaxoSmithKline Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.5.5 GlaxoSmithKline Recent Developments

7.6 Emergent BioSolutions

7.6.1 Emergent BioSolutions Profile

7.6.2 Emergent BioSolutions Main Business

7.6.3 Emergent BioSolutions Vaccine Administration Products, Services and Solutions

7.6.4 Emergent BioSolutions Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.6.5 Emergent BioSolutions Recent Developments

7.7 Johnson & Johnson

7.7.1 Johnson & Johnson Profile

7.7.2 Johnson & Johnson Main Business

7.7.3 Johnson & Johnson Vaccine Administration Products, Services and Solutions

7.7.4 Johnson & Johnson Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.7.5 Johnson & Johnson Recent Developments

7.8 CSL Limited

7.8.1 CSL Limited Profile

7.8.2 CSL Limited Main Business

7.8.3 CSL Limited Vaccine Administration Products, Services and Solutions

7.8.4 CSL Limited Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.8.5 CSL Limited Recent Developments

7.9 Serum Institute of India

7.9.1 Serum Institute of India Profile

7.9.2 Serum Institute of India Main Business

7.9.3 Serum Institute of India Vaccine Administration Products, Services and Solutions

7.9.4 Serum Institute of India Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.9.5 Serum Institute of India Recent Developments

7.10 Bharat Biotech

7.10.1 Bharat Biotech Profile

7.10.2 Bharat Biotech Main Business

7.10.3 Bharat Biotech Vaccine Administration Products, Services and Solutions

7.10.4 Bharat Biotech Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.10.5 Bharat Biotech Recent Developments

7.11 VBI Vaccines

7.11.1 VBI Vaccines Profile

7.11.2 VBI Vaccines Main Business

7.11.3 VBI Vaccines Vaccine Administration Products, Services and Solutions

7.11.4 VBI Vaccines Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.11.5 VBI Vaccines Recent Developments

7.12 Sinovac Biotech

7.12.1 Sinovac Biotech Profile

7.12.2 Sinovac Biotech Main Business

7.12.3 Sinovac Biotech Vaccine Administration Products, Services and Solutions

7.12.4 Sinovac Biotech Vaccine Administration Revenue (US$ Million) & (2019-2024)

7.12.5 Sinovac Biotech Recent Developments

8 Industry Chain Analysis

8.1 Vaccine Administration Industrial Chain

8.2 Vaccine Administration Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Vaccine Administration Sales Model

8.5.2 Sales Channel

8.5.3 Vaccine Administration Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Emergent Biosolutions

Johnson & Johnson

CSL Limited

Serum Institute of India

Bharat Biotech

VBI Vaccines

SINOVAC BIOTECH

List of Tables

Table 1. Vaccine Administration Market Trends

Table 2. Vaccine Administration Market Drivers & Opportunity

Table 3. Vaccine Administration Market Challenges

Table 4. Vaccine Administration Market Restraints

Table 5. Global Vaccine Administration Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Vaccine Administration Revenue Market Share by Company (2019-2024)

Table 7. Key Companies Vaccine Administration Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Vaccine Administration Product Type

Table 9. Key Companies Time to Begin Mass Production of Vaccine Administration

Table 10. Global Vaccine Administration Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Administration as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Vaccine Administration Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Vaccine Administration Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global Vaccine Administration Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global Vaccine Administration Sales Market Share in Value by Type (2019-2024) & (%)

Table 17. Global Vaccine Administration Sales Market Share in Value by Type (2025-2030) & (%)

Table 18. Global Vaccine Administration Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global Vaccine Administration Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global Vaccine Administration Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global Vaccine Administration Sales Market Share in Value by Application (2019-2024) & (%)

Table 22. Global Vaccine Administration Sales Market Share in Value by Application (2025-2030) & (%)

Table 23. Global Vaccine Administration Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 24. Global Vaccine Administration Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global Vaccine Administration Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global Vaccine Administration Sales Value by Region (2019-2024) & (%)

Table 27. Global Vaccine Administration Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions Vaccine Administration Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions Vaccine Administration Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions Vaccine Administration Sales Value, (2025-2030) & (US$ Million)

Table 31. Pfizer Basic Information List

Table 32. Pfizer Description and Business Overview

Table 33. Pfizer Vaccine Administration Products, Services and Solutions

Table 34. Revenue (US$ Million) in Vaccine Administration Business of Pfizer (2019-2024)

Table 35. Pfizer Recent Developments

Table 36. AstraZeneca Basic Information List

Table 37. AstraZeneca Description and Business Overview

Table 38. AstraZeneca Vaccine Administration Products, Services and Solutions

Table 39. Revenue (US$ Million) in Vaccine Administration Business of AstraZeneca (2019-2024)

Table 40. AstraZeneca Recent Developments

Table 41. Sanofi Aventis Basic Information List

Table 42. Sanofi Aventis Description and Business Overview

Table 43. Sanofi Aventis Vaccine Administration Products, Services and Solutions

Table 44. Revenue (US$ Million) in Vaccine Administration Business of Sanofi Aventis (2019-2024)

Table 45. Sanofi Aventis Recent Developments

Table 46. Merck Basic Information List

Table 47. Merck Description and Business Overview

Table 48. Merck Vaccine Administration Products, Services and Solutions

Table 49. Revenue (US$ Million) in Vaccine Administration Business of Merck (2019-2024)

Table 50. Merck Recent Developments

Table 51. GlaxoSmithKline Basic Information List

Table 52. GlaxoSmithKline Description and Business Overview

Table 53. GlaxoSmithKline Vaccine Administration Products, Services and Solutions

Table 54. Revenue (US$ Million) in Vaccine Administration Business of GlaxoSmithKline (2019-2024)

Table 55. GlaxoSmithKline Recent Developments

Table 56. Emergent BioSolutions Basic Information List

Table 57. Emergent BioSolutions Description and Business Overview

Table 58. Emergent BioSolutions Vaccine Administration Products, Services and Solutions

Table 59. Revenue (US$ Million) in Vaccine Administration Business of Emergent BioSolutions (2019-2024)

Table 60. Emergent BioSolutions Recent Developments

Table 61. Johnson & Johnson Basic Information List

Table 62. Johnson & Johnson Description and Business Overview

Table 63. Johnson & Johnson Vaccine Administration Products, Services and Solutions

Table 64. Revenue (US$ Million) in Vaccine Administration Business of Johnson & Johnson (2019-2024)

Table 65. Johnson & Johnson Recent Developments

Table 66. CSL Limited Basic Information List

Table 67. CSL Limited Description and Business Overview

Table 68. CSL Limited Vaccine Administration Products, Services and Solutions

Table 69. Revenue (US$ Million) in Vaccine Administration Business of CSL Limited (2019-2024)

Table 70. CSL Limited Recent Developments

Table 71. Serum Institute of India Basic Information List

Table 72. Serum Institute of India Description and Business Overview

Table 73. Serum Institute of India Vaccine Administration Products, Services and Solutions

Table 74. Revenue (US$ Million) in Vaccine Administration Business of Serum Institute of India (2019-2024)

Table 75. Serum Institute of India Recent Developments

Table 76. Bharat Biotech Basic Information List

Table 77. Bharat Biotech Description and Business Overview

Table 78. Bharat Biotech Vaccine Administration Products, Services and Solutions

Table 79. Revenue (US$ Million) in Vaccine Administration Business of Bharat Biotech (2019-2024)

Table 80. Bharat Biotech Recent Developments

Table 81. VBI Vaccines Basic Information List

Table 82. VBI Vaccines Description and Business Overview

Table 83. VBI Vaccines Vaccine Administration Products, Services and Solutions

Table 84. Revenue (US$ Million) in Vaccine Administration Business of VBI Vaccines (2019-2024)

Table 85. VBI Vaccines Recent Developments

Table 86. Sinovac Biotech Basic Information List

Table 87. Sinovac Biotech Description and Business Overview

Table 88. Sinovac Biotech Vaccine Administration Products, Services and Solutions

Table 89. Revenue (US$ Million) in Vaccine Administration Business of Sinovac Biotech (2019-2024)

Table 90. Sinovac Biotech Recent Developments

Table 91. Key Raw Materials Lists

Table 92. Raw Materials Key Suppliers Lists

Table 93. Vaccine Administration Downstream Customers

Table 94. Vaccine Administration Distributors List

Table 95. Research Programs/Design for This Report

Table 96. Key Data Information from Secondary Sources

Table 97. Key Data Information from Primary Sources

Table 98. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Vaccine Administration Product Picture

Figure 2. Global Vaccine Administration Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 4. Vaccine Administration Report Years Considered

Figure 5. Global Vaccine Administration Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine Administration Revenue in 2023

Figure 7. Vaccine Administration Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Viral Diseases Picture

Figure 9. Bacterial Diseases Picture

Figure 10. Global Vaccine Administration Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 11. Global Vaccine Administration Sales Value Market Share by Type, 2023 & 2030

Figure 12. Product Picture of Paediatrics

Figure 13. Product Picture of Adults

Figure 14. Global Vaccine Administration Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Vaccine Administration Sales Value Market Share by Application, 2023 & 2030

Figure 16. North America Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 17. North America Vaccine Administration Sales Value by Country (%), 2023 VS 2030

Figure 18. Europe Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 19. Europe Vaccine Administration Sales Value by Country (%), 2023 VS 2030

Figure 20. Asia Pacific Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 21. Asia Pacific Vaccine Administration Sales Value by Country (%), 2023 VS 2030

Figure 22. South America Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 23. South America Vaccine Administration Sales Value by Country (%), 2023 VS 2030

Figure 24. Middle East & Africa Vaccine Administration Sales Value (2019-2030) & (US$ Million)

Figure 25. Middle East & Africa Vaccine Administration Sales Value by Country (%), 2023 VS 2030

Figure 26. Key Countries/Regions Vaccine Administration Sales Value (%), (2019-2030)

Figure 27. United States Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 28. United States Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 29. United States Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 30. Europe Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 31. Europe Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 32. Europe Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 33. China Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 34. China Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 35. China Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 36. Japan Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 37. Japan Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 38. Japan Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 39. South Korea Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 40. South Korea Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 41. South Korea Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 42. Southeast Asia Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 44. Southeast Asia Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 45. India Vaccine Administration Sales Value, (2019-2030) & (US$ Million)

Figure 46. India Vaccine Administration Sales Value by Type (%), 2023 VS 2030

Figure 47. India Vaccine Administration Sales Value by Application (%), 2023 VS 2030

Figure 48. Vaccine Administration Industrial Chain

Figure 49. Vaccine Administration Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions